跳至主要内容
临床试验/CTRI/2025/03/082241
CTRI/2025/03/082241尚未招募2 期

Clinical trial to evaluate the efficacy of polyherbal hair oil(Habbul As, Amla, Mazu, Roghan kunjad) for Intithar al-Shar (diffuse hair loss): A Single arm, interventional study

Central Council for Research In Unani Medicine CCRUM New Delhi1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月4日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
1) Hair shedding Visual Scale

研究概览

简要总结

Hair loss is a normal physiological function of the body because of the asynchronous nature of the human hair cycle. Upto 100  hair often fall out each day. Increased hair loss over 100 hairs per day is a dermatological condition that affects both men and women. Diffuse hair loss (DHL) is a highly frequent and difficult issue that affects both gender , but young to middle-aged women are  more noticeable in this age group. Commonest DHL is chronic telogen effluvium(CTE) followed by female pattern hair loss (FPHL) and acute telogen effluvium(ATE). InUnani System of Medicine, hair loss is termed as Intithar a**l- SharUnani physicians have been treating this disease by different means and they have mentioned variousUnani drugs (single as well as compound) in the literature for its treatment. The present medical system does not have a specific treatment for it. Therefore, the proper topical combination with a multi targeted approach may improve hair loss and achieve a quicker outcome.

Keeping in view the above mentioned facts, it has been decided to evaluate the efficacy of poly herbal**hair oil  in the management of Intitharal*-S**har* (diffuse hair loss).

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • Male and female Patients of age between 18-40 years.
  • Hair loss more than 100 strands per day.
  • Patients who are willing to give consent and are able to follow up.

排除标准

  • Known cases of hypothyroidism.
  • Patients with male androgenetic alopecia, seborrhic dermatitis, lichen planopilaris, scalp psoriasis, tinea capitis, alopecia areata, trichotillomania & scaring alopecia .Patients with surgical correction of scalp hair loss (hair transplant) Patients who fail to give written consent.

结局指标

主要结局

1) Hair shedding Visual Scale

时间窗: 2 month

2) Trichoscopy

时间窗: 2 month

次要结局

  • 1) Hair pull test(2) Investigator Assessment using Photograph)

研究者

发起方
Central Council for Research In Unani Medicine CCRUM New Delhi
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验